UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Annals of oncology, 2020-07, Vol.31 (7), p.902-911

2020

Volltextzugriff (PDF)

Clinical Significance of Upper-arm Cephalic Vein Patency in Autogenous Radial-cephalic Wrist Fistulas for Hemodialysis

European journal of vascular and endovascular surgery, 2012-11, Vol.44 (5), p.514-520

2012

Volltextzugriff (PDF)

286O Clinical relevance of genetic mutation on treatment response to demethylating agents in myelodysplastic syndromes

Annals of oncology, 2015-12, Vol.26, p.ix85-ix85

2015

Volltextzugriff (PDF)

1231P Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer

Annals of oncology, 2023-10, Vol.34, p.S720-S720

2023

Volltextzugriff (PDF)

P-002 Recurrent genetic mutations in MDS and their prognostic roles on the 1st line decitabine treatment

Leukemia research, 2013-05, Vol.37, p.S23-S23

2013

Volltextzugriff (PDF)

577P A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC

Annals of oncology, 2023-11, Vol.34, p.S1696

2023

Volltextzugriff (PDF)

1371P First-line alectinib vs. brigatinib in advanced metastatic NSCLC with ALK rearrangement: Real-world data

Annals of oncology, 2023-10, Vol.34, p.S787-S787

2023

Volltextzugriff (PDF)

901P A phase II trial of neoadjuvant nivolumab, docetaxel, and cisplatin therapy followed by surgery and radiation therapy for resectable high-grade salivary gland carcinoma

Annals of oncology, 2024-09, Vol.35, p.S637-S637

2024

Volltextzugriff (PDF)

Bilateral Synchronous Breast Cancer: Imaging Findings of Mammography, US, MRI and FDG-PET

Ultrasound in medicine & biology, 2011, Vol.37 (8), p.S98-S99

2011

Volltextzugriff (PDF)

1655P Dabrafenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer

Annals of oncology, 2022-09, Vol.33, p.S1299

2022

Volltextzugriff (PDF)

Patterns of treatment outcomes in older patients with metastatic pancreatic cancer

Annals of oncology, 2017-11, Vol.28, p.x68-x68

2017

Volltextzugriff (PDF)

Clinical impact of FISH analysis in extramedullary plasmacytomas

Annals of oncology, 2017-09, Vol.28, p.v365-v365

2017

Volltextzugriff (PDF)

MA13.03 Combination of Bevacizumab + Atezolizumab (A) Who Progressed On A In Pretreated NSCLC Patients: An Open-Label, Two-Stage, Phase II Trial

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S925-S925

2021

Volltextzugriff (PDF)

1270P Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A single-arm, phase II multi-center trial

Annals of oncology, 2024-09, Vol.35, p.S812-S813

2024

Volltextzugriff (PDF)

1413P Multi-modal deep-learning model for real-time prediction of recurrence in early-stage esophageal cancer: A multi-modal approach

Annals of oncology, 2024-09, Vol.35, p.S883-S883

2024

Volltextzugriff (PDF)

EP11.03-38 Comparison of Real-World Outcomes in aNSCLC Patients Receiving 1L Immunotherapy Alone or in Combination with Chemotherapy

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S637

2023

Volltextzugriff (PDF)

933MO Longitudinal monitoring of circulating tumor DNA from plasma in patients with curative resected stage IA-IIIA EGFR mutant non-small cell lung cancer

Annals of oncology, 2022-09, Vol.33, p.S974

2022

Volltextzugriff (PDF)

Antioxidant Xanthones from the Pericarp of Garcinia mangostana (Mangosteen)

Journal of agricultural and food chemistry, 2006-03, Vol.54 (6), p.2077-2082

2006

Volltextzugriff (PDF)

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2023-11, Vol.34, p.S1608

2023

Volltextzugriff (PDF)

1338P Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial

Annals of oncology, 2023-10, Vol.34, p.S771-S772

2023

Volltextzugriff (PDF)

1395P Who will maintain as long-term responders more than 3 years with first- or second-generation EGFR TKI among EGFR mutant NSCLC?

Annals of oncology, 2020-09, Vol.31, p.S885-S885

2020

Volltextzugriff (PDF)

Clinical outcomes according to HPV status in oropharynx cancer patients following upfront definitive radiation therapy with policy of selective neck irradiation and reduced elective neck irradiation dose

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1224-1224

2020

Volltextzugriff (PDF)

1223P Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm+) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)

Annals of oncology, 2021-09, Vol.32, p.S971-S972

2021

Volltextzugriff (PDF)

193P Long-term survival in non-small cell lung cancer patients with metachronous brain-only oligorecurrence who underwent definitive treatment

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S803-S803

2021

Volltextzugriff (PDF)

P76.15 Osimertinib Improved Overall Survival in mEGFR NSCLC Patients With Leptomeningeal Metastases Regardless of T790M Mutational Status

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S592-S592

2021

Volltextzugriff (PDF)

1 – 25 von 213

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(180)
Mit Volltextzugriff
(197)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(59)
Humans
(34)
Physical Sciences
(28)
Biological And Medical Sciences
(23)
Male
(20)
Female
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Middle Aged
(14)
Adult
(12)
Aged
(11)
Animals
(10)
Mathematics
(10)
Microbiology
(10)
Physics
(10)
Astronomy & Astrophysics
(9)
Medical Sciences
(9)
Mice
(8)
Oncology
(8)
Surgery
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Clinical Significance of Upper-arm Cephalic Vein Patency in Autogenous Radial-cephalic Wrist Fistulas for Hemodialysis

286O Clinical relevance of genetic mutation on treatment response to demethylating agents in myelodysplastic syndromes

1231P Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer

P-002 Recurrent genetic mutations in MDS and their prognostic roles on the 1st line decitabine treatment

577P A study of the efficacy and safety of amivantamab in EGFR exon 20 insertion (E20I) mutations in NSCLC

1371P First-line alectinib vs. brigatinib in advanced metastatic NSCLC with ALK rearrangement: Real-world data

901P A phase II trial of neoadjuvant nivolumab, docetaxel, and cisplatin therapy followed by surgery and radiation therapy for resectable high-grade salivary gland carcinoma

Bilateral Synchronous Breast Cancer: Imaging Findings of Mammography, US, MRI and FDG-PET

1655P Dabrafenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer

Patterns of treatment outcomes in older patients with metastatic pancreatic cancer

Clinical impact of FISH analysis in extramedullary plasmacytomas

MA13.03 Combination of Bevacizumab + Atezolizumab (A) Who Progressed On A In Pretreated NSCLC Patients: An Open-Label, Two-Stage, Phase II Trial

1270P Lazertinib for patients with NSCLC harboring uncommon EGFR mutations: A single-arm, phase II multi-center trial

1413P Multi-modal deep-learning model for real-time prediction of recurrence in early-stage esophageal cancer: A multi-modal approach

EP11.03-38 Comparison of Real-World Outcomes in aNSCLC Patients Receiving 1L Immunotherapy Alone or in Combination with Chemotherapy

933MO Longitudinal monitoring of circulating tumor DNA from plasma in patients with curative resected stage IA-IIIA EGFR mutant non-small cell lung cancer

Antioxidant Xanthones from the Pericarp of Garcinia mangostana (Mangosteen)

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

1338P Cerebrospinal fluid pharmacokinetic study of lazertinib and pemetrexed in patients with EGFR-mutant non-small cell lung cancer with leptomeningeal metastases: KCSG21-01 LAZARUS trial

1395P Who will maintain as long-term responders more than 3 years with first- or second-generation EGFR TKI among EGFR mutant NSCLC?

Clinical outcomes according to HPV status in oropharynx cancer patients following upfront definitive radiation therapy with policy of selective neck irradiation and reduced elective neck irradiation dose

1223P Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm+) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)

193P Long-term survival in non-small cell lung cancer patients with metachronous brain-only oligorecurrence who underwent definitive treatment

P76.15 Osimertinib Improved Overall Survival in mEGFR NSCLC Patients With Leptomeningeal Metastases Regardless of T790M Mutational Status

Suchergebnisse filtern